IN VITRO DIAGNOSTICS ACT Genomics Co. Ltd. ACT Genomics raises $8mm in Series A round Molecular diagnostics start-up ACT Genomics Co. Ltd. raised $8mm in Series A funding from undisclosed new
Device Transactions Device firms raised a total of $1.6 billion in 2014’s second quarter, a significant increase – 123% – over Q1’s $714 million. In Q2 there were strong representations from late-stag
Exhibit 1 Top Alliances In June/July 2014 (Potential Deal Value in $M) *Potential deal value is the sum of up-front fees plus pre-commercialization money. Strategic Transactions Exhibit 2 Top Mergers